menu

Quintiles Library

Show Filters
Article
In 2012, the Agency for Healthcare Research and Quality (AHRQ) set out to develop the Registry of Patient Registries (RoPR) as a one-stop repository of information about patient registries focused on, but not exclusive to, U.S.-based registries. Michelle Leavy, manager for health policy in the real world late phase research program, is quoted in this BioWorld Today...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 25, 2015 – Quintiles, the world’s largest biopharmaceutical services company, has been named to Forbes magazine’s first-ever “America’s Best Employers” list as rated by more than 20,000 independent survey responses. Quintiles is ranked as the 30th best employer in the United States and comes in third in the “Drugs and Biotechnology”...
Read More
Press Release
SINGAPORE – March 25, 2015 – Quintiles Head of Asia Markets Anand Tharmaratnam, M.D., last night was honored as “Best Life Science Asian Male Executive of the Year” at the BioPharma Asia Industry Awards.  Dr. Tharmaratnam was selected in a vote of biopharmaceutical industry professionals from five distinguished executives shortlisted for the award. “On behalf of the...
Read More
Brochure
真实世界研究与临床后期肿瘤研究 尽早向患者提供有效的治疗方法 专业支持可帮助成功并改善诊疗
Read More
Brochure
The oncology environment is rapidly changing, and the integration of real world research throughout the product lifecycle is becoming increasingly critical to product development and commercialization. Quintiles’ integrated approach to real-world and late phase oncology research is designed to facilitate your success and bring better treatments to patients sooner.
Read More
Fact Sheet
Quintiles’ HTA Watch is a web-based service offering instant access to a global repository of published HTA reports from nearly 100 agencies in 32 countries, providing regularly updated assessments to help inform life sciences and healthcare companies’ strategic decision-making*.  In this edition of our HTA uncovered series, we'll explore Real world evidence and...
Read More
Article
The Cardiac Safety arena is evolving and regulators are considering issuing modified requirements to allow cardiac safety testing to be conducted earlier in the development process. In this article, Quintiles cardiac safety experts provide the historic context for cardiac safety testing and options for moving forward.
Read More
Article
As increasing numbers of highly-successful biologics come off patent, biosimilars are a promising area for investment, offering growth potential that is lacking in many other areas of the biopharma market. This two-part series examines the environment for third-party capital providers. Part 1 provides an introduction to this complex area, describing key players entering...
Read More
White Paper
Strategies for dose escalation during first-in-human studies are critical for volunteer safety and for study success. Decisions regarding dose escalation involve balancing three elements: risks to individual volunteers; risks of failing to identify the correct dose range to use in subsequent studies; and risks of delaying or stopping development of a potentially useful...
Explore More
White Paper
Value-based medicine is giving patients more power as consumers of healthcare products -- and the industry must respond. A recurring theme at EVF, experts and speakers returned repeatedly to the notion of the patient as consumer, and what payers, pharma, providers and practitioners must do to accommodate this increasingly powerful stakeholder group.
Explore More
Brochure
By blending specialized scientific and operational expertise with innovative technology, Quintiles can help determine the right research questions, then develop the best study designs and implement them efficiently to support your cardiovascular portfolio evidence requirements.
Read More
Article
Medical outcome trials--large-scale, long-duration clinical trials with hard endpoints, including morbidity and mortality-can answer critical questions about product safety and efficacy and are among the most expensive and logistically challenging trials in the entire product life cycle. They can show long-term safety in therapies for chronic diseases such as type 2...
Read More
Brochure
Health Engagement & Communications is an agency positioned at the forefront of innovation and is part of Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services. Immersed in healthcare, we build engaging, innovative experiences for patients and healthcare professionals to drive meaningful change and improve...
Read More
Article
Biologics are truly innovative therapies, but they are extremely expensive. The development of biosimilar medicines is an emerging field that is generating high levels of interest within industry, and offers the prospect of increasing patient access to these highly effective medicines. Currently, the global biosimilars market includes monoclonal antibody (mAb) biosimilars...
Read More
Article
Biopharmaceutical companies’ commercial models must respond to an ever-changing marketplace, with increasing demands from both payers and patients for better care, improved outcomes, more affordable therapies, and increased speed to market. In a recent interview, George Esgro, Vice President & Head, U.S. Commercial Solutions, Quintiles, discussed how strategic...
Read More
Fact Sheet
The vast nature of phenotypes across asthma – COPD, IPF and others – is just one of the many challenges in managing early phase respiratory clinical research. Specialized equipment, facilities, medical and scientific expertise are required to gain the best possible data from these early studies.
Read More
Fact Sheet
Generating the evidence you need to demonstrate the value stakeholders demand in the real world.
Read More
Fact Sheet
セントラル・ラボラトリーサービス - 高品質のラボデータをタイムリーに:冊子 今日の薬剤開発環境のニーズを満たすには柔軟性が必要です。長期的視点でのセントラル・ラボサービスのパートナーが必要な場合、豊富な経験・知識を有し、世界各地にてサービスの提供が可能なセントラル・ラボが必須となります。 クインタイルズでは、アメリカ大陸、ヨーロッパ、アジア、アフリカの各地域に自社のセントラルラボ(QLAB)を所有し、安全性項目検査のみでなくバイオ分析、ADME、ゲノミクス等の様々なセントラルサービスをグローバルに展開しています。 これまでの経験や蓄積した知識を活用し、お客様のプロジェクトに最適なソリューションの提供が可能です。 コンテンツは日本語です。
Read More
Press Release
RESEARCH TRIANGLE PARK, NC – February 27, 2015 – Quintiles CEO Tom Pike will present at the 2015 Barclays Global Healthcare Conference on Tuesday, March 10, 2015 in Miami at the Loews Miami Hotel. The Quintiles presentation will begin at 11:15 a.m. (EST). Investors may access a live audio webcast of the presentation on the Quintiles Investor Relations website at...
Read More